Brief: Livzon Pharma plans industry fund, unit in alliance with Epirus Switzerland

Epirus Biopharmaceuticals

24/09/2015 13:15

Sept 24 (Reuters) - Livzon Pharmaceutical Group Inc 
 000513.SZ  1513.HK  
    * Says unit Livzon Mabpharm signs collaboration agreement 
with Switzerland's Epirus Switzerland 
    * Says plans to set up industry fund worth 500 million yuan  
($78.35 million) with partner 
 
 
    Source text in Chinese: http://bit.ly/1iy9eAM; 
http://bit.ly/1VcnM5B 
    Further company coverage:  000513.SZ  1513.HK  
 
($1 = 6.3818 Chinese yuan renminbi) 
 
 (Reporting by Hong Kong and Singapore newsrooms) 
 ((chyenyee.lee@thomsonreuters.com; (852) 2843-6441; Reuters 
Messaging: chyenyee.lee.reuters.com@reuters.net))